Your browser doesn't support javascript.
loading
Efficacy of Cabozantinib for Papillary Compared With Clear-cell Renal Cell Carcinoma Following Immune Checkpoint Inhibitor Treatment.
Tachibana, Hidekazu; Inakawa, Toru; Nemoto, Yuki; Ishihara, Hiroki; Fukuda, Hironori; Yoshida, Kazuhiko; Iizuka, Junpei; Hashimoto, Yasunobu; Tanabe, Kazunari; Kondo, Tsunenori; Takagi, Toshio.
Afiliação
  • Tachibana H; Department of Urology, Saiseikai Kazo Hospital, Saitama, Japan.
  • Inakawa T; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Nemoto Y; Department of Urology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
  • Ishihara H; Department of Urology, Saiseikai Kawaguchi Hospital, Saitama, Japan.
  • Fukuda H; Department of Urology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
  • Yoshida K; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Iizuka J; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Hashimoto Y; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Tanabe K; Department of Urology, Saiseikai Kawaguchi Hospital, Saitama, Japan.
  • Kondo T; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Takagi T; Department of Urology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan; kondo.tsunenori@twmu.ac.jp.
Anticancer Res ; 42(6): 3151-3158, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35641290

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article